CMRA (Comera Life Sciences Holdings) Other Current Payables: $0.00 Mil (As of Sep. 2023)


What is Comera Life Sciences Holdings Other Current Payables?

Comera Life Sciences Holdings CMRA Other Current Payables is $0.00 Mil as of Sep. 2023.

Comera Life Sciences Holdings's Other Current Payables for the quarter that ended in Sep. 2023 was $0.00 Mil.

Comera Life Sciences Holdings Other Current Payables Related Terms

Comera Life Sciences Holdings Other Current Payables Historical Data

* Premium members only.

The historical data trend for Comera Life Sciences Holdings's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Comera Life Sciences Holdings Other Current Payables Chart

Comera Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22
Other Current Payables
0.00 0.00 0.00

Comera Life Sciences Holdings Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Comera Life Sciences Holdings Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
Comera Life Sciences Holdings (CMRA) has a Other Current Payables of $0.00 Mil as of Sep. 2023. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Comera Life Sciences Holdings and its competitors.
Is Comera Life Sciences Holdings' Other Current Payables too high?
Comera Life Sciences Holdings' current Other Current Payables is $0.00 Mil.
How does Comera Life Sciences Holdings' Other Current Payables compare to FREQ and BNTC?
Comera Life Sciences Holdings' Other Current Payables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Comera Life Sciences Holdings and its competitors. Comera Life Sciences Holdings's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Comera Life Sciences Holdings stock overvalued right now?
Comera Life Sciences Holdings (CMRA) has a current Other Current Payables of $0.00 Mil. The current Other Current Payables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Comera Life Sciences Holdings (CMRA), the current Other Current Payables is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Comera Life Sciences Holdings Business Description

Address 12 Gill Street, Suite 4650, Woburn, MA, USA, 01801
Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated to promoting formulation science and technology to transform essential biologic medicines from intravenous to subcutaneous forms. Comera's internal portfolio of proprietary techniques known as the SQore platform is designed to potentially transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, and optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to the Company's partners' biologic medicines to deliver enhanced formulations that facilitate self-injectable care.